Key result
Periodontal disease is associated with metabolic syndrome components including obesity, dyslipidemia, and hypertension.
Answers are grounded in this paper and cite their sources.
Periodontal disease is a complex and progressive chronic inflammatory condition that leads to the loss of alveolar bone and teeth. It has been associated with various systemic diseases, including diabetes mellitus and obesity, among others. Some of these conditions are part of the metabolic syndrome cluster, a group of interconnected systemic diseases that significantly raise the risk of cardiovascular diseases, diabetes mellitus, and stroke. The metabolic syndrome cluster encompasses central obesity, dyslipidemia, insulin resistance, and hypertension. In this review, our objective is to investigate the correlation between periodontal disease and the components and outcomes of the metabolic syndrome cluster. By doing so, we aim to gain insights into the fundamental mechanisms that link each systemic condition with the metabolic syndrome. This deeper understanding of the interplay between these conditions and periodontal disease can pave the way for more effective treatments that take into account the broader impact of managing periodontal disease on the comprehensive treatment of systemic diseases, and vice versa.
No takes yet. Share an insight, caveat, or question.
Aizenbud et al. (2023) conducted a review in Periodontal disease and metabolic syndrome. Periodontal disease was evaluated on Association with components and outcomes of metabolic syndrome (central obesity, dyslipidemia, insulin resistance, and hypertension). Periodontal disease is associated with components of the metabolic syndrome cluster (central obesity, dyslipidemia, insulin resistance, hypertension), with no quantitative estimates reported.
Synapse has enriched 10 related papers. Consider them for comparative context: